Publication | Open Access
Venetoclax plus rituximab in relapsed or refractory chronic lymphocytic leukaemia: a phase 1b study
321
Citations
21
References
2017
Year
Phase 1BLymphoid NeoplasiaHematological MalignancyMedicineImmunologyHematologyPathologyImmune Checkpoint InhibitorAutoimmunityAdult T-cell Leukemia-lymphomaImmunotherapyOncologyCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1